Keyword: ISOL
Paper Title Other Keywords Page
WEVIR11 Safety System for the Respect of Nuclear Requirements of SPIRAL2 Facility controls, experiment, operation, linac 57
  • P. Anger, V.C. Cingal, JC-P. Pacary, S.P.G. Perret-Gatel, A. Savalle
    GANIL, Caen, France
  The SPIRAL2 Facility at GANIL is based on the construction of a superconducting ion CW LINAC (up to 5 mA - 40 MeV deuteron beams and up to 1 mA - 14.5 MeV/u heavy ion beams) with 2 experimental areas called S3 and NFS. For safety classified systems, SPIRAL2 project system engineering sets up a specific reinforced process, based on V-Model, to validate, at each step, all the requirements (technical, nuclear safety, quality, reliability, interfaces…) from the functional specifications to the final validation. Since 2016, safety devices have been under construction and in test phase. These tests which are pre-requisites to deliver the first beam demonstrated that both functional and safety requirements are fulfilled. Currently, all of them are in operation for the LINAC and NFS commissioning phases. This contribution will describe the requirements, the methodology, the quality processes, the technical studies, the failure mode and effects analysis, the tests, the status and will propose you a feedback.  
video icon
DOI • reference for this paper ※  
About • paper received ※ 01 June 2020       paper accepted ※ 14 June 2020       issue date ※ 15 June 2020  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)  
THVIR13 CERN-MEDICIS: A Unique Facility for the Production of Non-Conventional Radionuclides for the Medical Research target, proton, radiation, operation 75
  • C. Duchemin, E. Barbero-Soto, A.P. Bernardes, R. Catherall, E. Chevallay, A. Dorsival, V.N. Fedosseev, P. Fernier, S.S. Gilardoni, J.L. Grenard, L. Lambert, G. Lilli, G. Lilli, G. Lunghi, B.A. Marsh, Y. Martinez Palenzuela, S. Marzari, F. Pozzi, J. Riegert, S. Rothe, T. Stora, J. Vollaire, N.-T. Vuong, S. Wilkins
    CERN, Meyrin, Switzerland
  • T.E. Cocolios, R. Heinke
    KU Leuven, Leuven, Belgium
  • F. Haddad
    Cyclotron ARRONAX, Saint-Herblain, France
  • M.A. Khan
    PINSTECH, Islamabad, Pakistan
  • N. Michel
    SUBATECH, Nantes, France
  • J.P. Ramos
    SCK•CEN, Mol, Belgium
  • Z. Talip, N.P. van der Meulen
    PSI, Villigen PSI, Switzerland
  • K. Wendt
    Johannes Gutenberg University Mainz, Institut für Physik, Mainz, Germany
  • K. Wendt
    Mainz University, Mainz, Germany
  The MEDICIS facility is a unique facility located at CERN dedicated to the production of non-conventional radionuclides for research and development in imaging, diagnostics and radiation therapy. It exploits in a Class A work sector, a dedicated isotope separator beam line, a target irradiation station at the 1.4 GeV Proton Synchroton Booster (PSB) and receives activated targets from external institutes during CERN Long Shut-Downs. The target is heated up at high temperatures to allow for the diffusion and effusion of the atoms out of the target that are subsequently ionized. The ions are accelerated and sent through an off-line mass separator. The radionuclide of interest is extracted through mass separation and implanted into a thin metallic collection foil. After collection, the batch is prepared to be dispatched to a research center. In the near-future, the radiochemistry process will also be performed in MEDICIS. Since its commissioning in December 2017, the facility has provided novel radionuclides such as Tb-149, Tb-155, Tm-165, Er-169 and Yb-175 with high specific activity, some for the first time, to European research institutes part of the collaboration.  
video icon
DOI • reference for this paper ※  
About • paper received ※ 09 June 2020       paper accepted ※ 12 June 2020       issue date ※ 23 September 2020  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)